Spectrum of cellular responses to pyriplatin, a monofunctional cationic antineoplastic platinum(II) compound, in human cancer cells
about
Phenanthriplatin, a monofunctional DNA-binding platinum anticancer drug candidate with unusual potency and cellular activity profileThe Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) ProdrugsA monofunctional platinum complex coordinated to a rhodium metalloinsertor selectively binds mismatched DNA in the minor groove.Understanding and improving platinum anticancer drugs--phenanthriplatinThird row transition metals for the treatment of cancerMonofunctional platinum-DNA adducts are strong inhibitors of transcription and substrates for nucleotide excision repair in live mammalian cellsAnalysis of the DNA damage produced by a platinum-acridine antitumor agent and its effects in NCI-H460 lung cancer cellsSynthesis, characterization, and evaluation of cis-diphenyl pyridineamine platinum(II) complexes as potential anti-breast cancer agentsMefloquine exposure induces cell cycle delay and reveals stage-specific expression of the pfmdr1 gene.Monofunctional and higher-valent platinum anticancer agents.The cell's nucleolus: an emerging target for chemotherapeutic intervention.Mechanistic added value of a trans-Sulfonamide-Platinum-Complex in human melanoma cell lines and synergism with cis-PlatinSynthetic methods for the preparation of platinum anticancer complexes.H2AX a promising biomarker for lung cancer: a review.Platinum-based drugs: past, present and future.Monofunctional platinum(II) complexes with potent tumor cell growth inhibitory activity: the effect of a hydrogen-bond donor/acceptor N-heterocyclic ligand.The chiral potential of phenanthriplatin and its influence on guanine binding.Anti-cancer characteristics and ototoxicity of platinum(II) amine complexes with only one leaving ligand.Simultaneous delivery of olaparib and carboplatin in PEGylated liposomes imparts this drug combination hypersensitivity and selectivity for breast tumor cells.
P2860
Q24625759-8FDB631A-2A88-44B8-BEDA-FF718A9E8F9EQ28066801-F65458FC-0BCF-4583-AC1E-ABBE292009F5Q30996085-2B3A326A-D67F-4F3B-B5D4-E2F54C0FE927Q34396623-31F53BDA-7245-4F99-867C-3093BBF490E1Q35128394-B6BAC6DD-3AE3-4728-8830-4D8712FB2417Q35729416-1C44010B-6CC0-45B4-9BA5-D7AE8D3DC443Q36074567-0C09AE23-930B-447C-A178-DC9C02FC7E55Q36270717-57A19BF5-90C6-425F-9215-F462C9D94676Q36558336-A397545F-0132-4E6F-A0FF-66B7B0AB3733Q37282213-B52DE6AC-6E53-4761-8127-41E52DE0007DQ37484539-741D8B6F-72EF-4238-841F-43DCC7D55B5DQ37663479-DA29D76B-3288-46EA-A8DB-489F34ED773EQ37722632-7025EEC0-0CEF-456F-8CC9-ED51A0D86C0BQ38155902-F7781CF5-9AE2-45D1-AC00-DBDE1D2BE171Q38737115-AAA77ADC-13B3-4C92-97EA-1DFF3E05F4B4Q38998145-0058CDEF-4694-40E0-A6A1-22FBDDF39C12Q41984036-6AAF2364-04A6-45E9-9C3D-16D848DDE5BAQ55300936-0737F048-11A9-48E6-A1EC-34BF5ED10CCBQ55504427-D6E71298-6319-41CC-A7C3-8FF479C6735D
P2860
Spectrum of cellular responses to pyriplatin, a monofunctional cationic antineoplastic platinum(II) compound, in human cancer cells
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Spectrum of cellular responses ...... ompound, in human cancer cells
@ast
Spectrum of cellular responses ...... ompound, in human cancer cells
@en
type
label
Spectrum of cellular responses ...... ompound, in human cancer cells
@ast
Spectrum of cellular responses ...... ompound, in human cancer cells
@en
prefLabel
Spectrum of cellular responses ...... ompound, in human cancer cells
@ast
Spectrum of cellular responses ...... ompound, in human cancer cells
@en
P2093
P2860
P50
P1476
Spectrum of cellular responses ...... ompound, in human cancer cells
@en
P2093
Christian Gespach
Eric Raymond
Esteban Cvitkovic
Eugenio Erba
Maria Serova
Shahin Emami
Stephen J Lippard
P2860
P304
P356
10.1158/1535-7163.MCT-11-0250
P577
2011-07-12T00:00:00Z